Evaluation of serum kallistatin level as a predictor of esophageal varices in cirrhotic patients

References

• Garcia–Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51(4):1445–1449.
   PubMed Web of Science ®Google Scholar
• Groszmann R, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353(21):2254–2261.
   PubMed Web of Science ®Google Scholar
• Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–272.
   Web of Science ®Google Scholar
• D’Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–1193.
   PubMed Web of Science ®Google Scholar
• De Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
   PubMed Web of Science ®Google Scholar
• Chen V, Chao L, Pimenta D, et al. Identification of a major heparin-binding site in kallistatin. J Biol Chem. 2001;276(2):1276–1284.
   Web of Science ®Google Scholar
• Chao J, Schmaier A, Chen L, et al. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med. 1996;S127(6):612–620.
   Google Scholar
• Miao R, Agata J, Chao L, et al. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 2002;100:3245–3252.
   PubMed Web of Science ®Google Scholar
• Chao J, Bledsoe G, Chao L. Protective role of kallistatin in vascular and organ injury. Hypertension. 2016;68(3):533–541.
   PubMed Web of Science ®Google Scholar
• Shen B, Hagiwara M, Yao Y, et al. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 2008;51:1358–1365.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Lv Y, Pang S, et al. Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. Acta Pharm Sin. 2015;B 5:194–200.
   Google Scholar
• Madhotra R, Mulcahy H, Willner I, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34(1):81–85.
   Web of Science ®Google Scholar
• Cales P, Oberti F, Bernard-Chabert B, et al. Evaluation of Baveno recommendations for grading esophageal varices. J Hepatol. 2003;39(4):658–659.
   Web of Science ®Google Scholar
• Loftus W, Chow L, Metreweli C. Sonographic measurement of splenic length: correlation with measurement at autopsy. J Clin Ultrasound. 1999;27(2):71–74.
   Web of Science ®Google Scholar
• Runyon BA, Commitee APG. Management of adult patients with ascites. AASLD PRACTICE GUIDELINE due to cirrhosis: update 2012., revised and updated guideline based on the previously published version. Hepatology. 2009;49:2087–2107.
   PubMed Web of Science ®Google Scholar
• CG C, Turcotte JG. Surgery and portal hypertension. The liver and portal hypertension. Philadelphia: Saunders; 1964.
   Google Scholar
• Paquet K. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices - a prospective controlled randomized trial. Endoscopy. 1982;14(1):4–5.
   PubMed Web of Science ®Google Scholar
• Pungpapong S, Keaveny A, Raimondo M, et al. Accuracy and interobserver agreement of small-caliber vs.Conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007;39(08):673–680.
   Google Scholar
• Tafarel J, Tolentino L, Correa L, et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. Eur J Gastroenterol Hepatol. 2011;23(9):754–758.
   Web of Science ®Google Scholar
• El Toukhy N. Issa H: predictive and prognostic vale of von Willebrand factor in patients with cirrhosis and esophageal varices. Afro-Egypt J Infect Endem Dis. 2019;9(1):67–73.
   Google Scholar
• AbdelMaksoud MA, Jouda A, Fathy T, et al. Role of plasma von willebrand factor-antigen in predicting the presence of esophageal varices and occurrence of its bleeding in cirrhotic patient. Afro-Egypt J Infect Endem Dis. 2019;9(2):139–149.
   Google Scholar
• Emam E, Ramadan A, Badway M, et al. Prediction of oesophageal varices in patients with compensated cirrhosis: A novel scoring system. Arab J Gastroenterol. 2009;10(4):129–134.
   Google Scholar
• Kraja B, Mone I, Akshija I, et al. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017;23(26):4806.
   Web of Science ®Google Scholar
• Mandal L, Mandal S, Bandyopadhyay D, et al. Correlation of portal vein diameter and splenic size with gastro-oesophageal varices in cirrhosis of liver. J Indian Acad Clin Med. 2011;12(4):266–270.
   Google Scholar
• Kedar RP, Merchant SA, Malde HH, et al. Multiple reflective channels in the spleen: A sonographic sign of portal hypertension. Abdom Imaging. 1994;19:453–458.
   Google Scholar